Your browser doesn't support javascript.
loading
Case Report: A case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer.
Moriyama, Etsuko; Nagasu, Sachiko; Tanaka, Toshimitsu; Shimotsuura, Yasutaka; Ono, Takeharu; Umeno, Hirohito; Akiba, Jun; Kawahara, Akihiko; Fujita, Fumihiko; Kawaguchi, Takumi; Miwa, Keisuke.
Afiliación
  • Moriyama E; Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume, Japan.
  • Nagasu S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Tanaka T; Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume, Japan.
  • Shimotsuura Y; Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Ono T; Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume, Japan.
  • Umeno H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Akiba J; Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume, Japan.
  • Kawahara A; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Fujita F; Department of Otolaryngology, Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Kawaguchi T; Department of Otolaryngology, Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Miwa K; Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan.
Front Oncol ; 13: 1247435, 2023.
Article en En | MEDLINE | ID: mdl-37601665

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón